Le Monde
Europe · 3 hrs ago
✦ 72✓ Factual
Pancreatic cancers: New drug doubles survival rate as France rolls out prevention program
72Quality
0Ratings
0Comments
AI Analysis
Quality 72/100
Partisan intensity 15/100
ObjectivePartisan
Low partisan intensity — consistent with factual reporting⚠ Misleading headline
A new drug called daraxonrasib has shown improved survival rates for metastatic pancreatic cancer in an international trial, and France is expanding a personalized screening program across additional medical centers.
Pancreatic cancers: New drug doubles survival rate as France rolls out prevention program
In cases of metastatic pancreatic tumors, daraxonrasib has been shown to drastically increase survival rates, according to an international trial presented at the American Society of Clinical Oncology congress on Sunday. In France, a personalized screening and prevention program, launched by the Gustave-Roussy Institute has been extended to eight additional centers.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!